150 related articles for article (PubMed ID: 32859224)
1. Pulmonary epithelial-myoepithelial carcinoma without AKT1, HRAS or PIK3CA mutations: a case report.
Yanagawa N; Sato A; Nishiya M; Suzuki M; Sugimoto R; Osakabe M; Uesugi N; Saito H; Sugai T
Diagn Pathol; 2020 Aug; 15(1):105. PubMed ID: 32859224
[TBL] [Abstract][Full Text] [Related]
2. Adenomyoepitheliomas of the Breast Frequently Harbor Recurrent Hotspot Mutations in PIK3-AKT Pathway-related Genes and a Subset Show Genetic Similarity to Salivary Gland Epithelial-Myoepithelial Carcinoma.
Lubin D; Toorens E; Zhang PJ; Jaffer S; Baraban E; Bleiweiss IJ; Nayak A
Am J Surg Pathol; 2019 Jul; 43(7):1005-1013. PubMed ID: 31094929
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic Significance of HRAS Mutations in Epithelial-Myoepithelial Carcinomas Exhibiting a Broad Histopathologic Spectrum.
Urano M; Nakaguro M; Yamamoto Y; Hirai H; Tanigawa M; Saigusa N; Shimizu A; Tsukahara K; Tada Y; Sakurai K; Isomura M; Okumura Y; Yamaguchi H; Matsubayashi J; Nagao T
Am J Surg Pathol; 2019 Jul; 43(7):984-994. PubMed ID: 30994537
[TBL] [Abstract][Full Text] [Related]
4. [A Rare Case of Pulmonary Epithelial-myoepithelial Carcinoma: Case Report and Literature Review].
Chen L; Li Q; Fu G; Ge M
Zhongguo Fei Ai Za Zhi; 2020 Feb; 23(2):127-132. PubMed ID: 32093457
[TBL] [Abstract][Full Text] [Related]
5. Epithelial-Myoepithelial Carcinoma of the Salivary Gland Harboring HRAS Codon 61 Mutations With Lung Metastasis.
Hsieh MS; Chen JS; Lee YH; Chou YH
Int J Surg Pathol; 2016 May; 24(3):227-31. PubMed ID: 26675036
[TBL] [Abstract][Full Text] [Related]
6. The Diagnostic Utility of RAS Q61R Mutation-specific Immunohistochemistry in Epithelial-Myoepithelial Carcinoma.
Nakaguro M; Tanigawa M; Hirai H; Yamamoto Y; Urano M; Takahashi RH; Sukeda A; Okumura Y; Honda S; Tasaki K; Shimizu A; Tsukahara K; Tada Y; Matsubayashi J; Faquin WC; Sadow PM; Nagao T
Am J Surg Pathol; 2021 Jul; 45(7):885-894. PubMed ID: 33481388
[TBL] [Abstract][Full Text] [Related]
7. Sclerosing Polycystic Adenoma of Salivary Glands: A Novel Neoplasm Characterized by PI3K-AKT Pathway Alterations-New Insights Into a Challenging Entity.
Skálová A; Baněčková M; Laco J; Di Palma S; Agaimy A; Ptáková N; Costes-Martineau V; Petersson BF; van den Hout MFCM; de Rezende G; Klubíčková N; Koblížek M; Koshyk O; Vaneček T; Leivo I
Am J Surg Pathol; 2022 Feb; 46(2):268-280. PubMed ID: 34510113
[TBL] [Abstract][Full Text] [Related]
8. Epithelial-Myoepithelial Carcinoma.
Nakaguro M; Nagao T
Surg Pathol Clin; 2021 Mar; 14(1):97-109. PubMed ID: 33526226
[TBL] [Abstract][Full Text] [Related]
9. Mammary Epithelial-Myoepithelial Carcinoma: Report of a Case With HRAS and PIK3CA Mutations by Next-Generation Sequencing.
Baum JE; Sung KJ; Tran H; Song W; Ginter PS
Int J Surg Pathol; 2019 Jun; 27(4):441-445. PubMed ID: 30585117
[TBL] [Abstract][Full Text] [Related]
10. CDKN2A loss and PIK3CA mutation in myoepithelial-like metaplastic breast cancer.
Bartels S; van Luttikhuizen JL; Christgen M; Mägel L; Luft A; Hänzelmann S; Lehmann U; Schlegelberger B; Leo F; Steinemann D; Kreipe H
J Pathol; 2018 Jul; 245(3):373-383. PubMed ID: 29708279
[TBL] [Abstract][Full Text] [Related]
11. Clear Cell Squamous Cell Carcinoma of the Maxillary Gingiva Associated with PIK3CA and HRAS Mutations: Report of a Case and Literature Review.
Hirose K; Shibahara T; Teramoto A; Usami Y; Ono S; Iwamoto Y; Murakami S; Oya K; Uzawa N; Motooka D; Hori Y; Morii E; Toyosawa S
Head Neck Pathol; 2023 Dec; 17(4):1026-1033. PubMed ID: 37735286
[TBL] [Abstract][Full Text] [Related]
12. Salivary epithelial-myoepithelial carcinoma: clinical, morphological and molecular features.
De Cecio R; Cantile M; Fulciniti F; Botti G; Foschini MP; Losito NS
Pathologica; 2017 Mar; 109(1):1-8. PubMed ID: 28635988
[TBL] [Abstract][Full Text] [Related]
13. New Insights into Tumor Heterogeneity: A Case of Solid-Oncocytic Epithelial-Myoepithelial Carcinoma of the Parotid Gland Harboring a HRAS and Heterogeneous Terminating ARID1A Mutation.
Rupp NJ; Brada M; Skálová A; Bode B; Broglie MA; Morand GB; Rechsteiner M; Freiberger SN
Head Neck Pathol; 2020 Jun; 14(2):554-558. PubMed ID: 31309433
[TBL] [Abstract][Full Text] [Related]
14.
Goto K; Maeda D; Kudo-Asabe Y; Hibiya T; Hayashi A; Fukayama M; Ohashi K; Goto A
J Clin Pathol; 2017 May; 70(5):424-427. PubMed ID: 27742746
[TBL] [Abstract][Full Text] [Related]
15. HRAS mutations in epithelial-myoepithelial carcinoma.
Chiosea SI; Miller M; Seethala RR
Head Neck Pathol; 2014 Jun; 8(2):146-50. PubMed ID: 24277618
[TBL] [Abstract][Full Text] [Related]
16. Mutational screening of RET, HRAS, KRAS, NRAS, BRAF, AKT1, and CTNNB1 in medullary thyroid carcinoma.
Schulten HJ; Al-Maghrabi J; Al-Ghamdi K; Salama S; Al-Muhayawi S; Chaudhary A; Hamour O; Abuzenadah A; Gari M; Al-Qahtani M
Anticancer Res; 2011 Dec; 31(12):4179-83. PubMed ID: 22199277
[TBL] [Abstract][Full Text] [Related]
17. Clinical Impact and Prognostic Role of KRAS/BRAF/PIK3CA Mutations in Stage I Colorectal Cancer.
Reggiani Bonetti L; Barresi V; Maiorana A; Manfredini S; Caprera C; Bettelli S
Dis Markers; 2018; 2018():2959801. PubMed ID: 30018674
[TBL] [Abstract][Full Text] [Related]
18. Mutations in FGFR3 and PIK3CA, singly or combined with RAS and AKT1, are associated with AKT but not with MAPK pathway activation in urothelial bladder cancer.
Juanpere N; Agell L; Lorenzo M; de Muga S; López-Vilaró L; Murillo R; Mojal S; Serrano S; Lorente JA; Lloreta J; Hernández S
Hum Pathol; 2012 Oct; 43(10):1573-82. PubMed ID: 22417847
[TBL] [Abstract][Full Text] [Related]
19. A rare case of primary peripheral epithelial myoepithelial carcinoma of lung: Case report and literature review.
Shen C; Wang X; Che G
Medicine (Baltimore); 2016 Aug; 95(35):e4371. PubMed ID: 27583848
[TBL] [Abstract][Full Text] [Related]
20. Primary pulmonary epithelial-myoepithelial carcinoma: Report of a rare and under-diagnosed low-grade malignancy.
Sharma S; Tayal A; Khatri S; Mohapatra SG; Mohanty SK
J Cancer Res Ther; 2022; 18(3):795-800. PubMed ID: 35900560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
